Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OMER
#2177
Omeros Corporation - Common Stock
19.6
3
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.01%
Monthly Change
+7.27%
6 month change
+70.55%
Year Change
+373.01%
Previous Close
19.8
3
Open
19.7
6
Low
19.4
7
High
20.2
4
Markets
US Stock Market
Healthcare
Biotechnology
OMER
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
61.93 M
62.73 M
62.83 M
57.94 M
58.06 M
72 M
72.39 M
Valuation ratios
Enterprise value
1.11 B
616.63 M
460.52 M
396.68 M
758.59 M
1.3 B
1.38 B
Price to earnings ratio
—
2.06
3.26
1.75
3.67
-343.5
10.7
Price to sales ratio
—
225.72
88.65
137.61
361.69
1 222.86
—
Price to cash flow ratio
—
-3.65
-1.8
2.76
3.86
-9.4
—
Price to book ratio
—
16.86
1.82
8.26
3.15
-9
—
Enterprise value to EBITDA ratio
-11.39
-3.65
-2.9
-2.45
-4.55
-10.71
—
Profitability ratios
Return on assets %
-0.76
0.46
0.08
-0.31
-0.57
-0.01
0.05
Return on equity %
1.14
8.17
0.55
4.72
0.86
0.03
-0.26
Return on invested capital %
-1 158.43
-557.87
-227.34
-246.66
-365.86
-548.91
0.18
Gross margin %
98.78
100
100
100
100
100
97.2
Operating margin %
-149.84
-9 775.73
-9 309.91
-10.97 K
-10.65 K
-13.77 K
0.26
EBITDA margin %
-132.21
-9 518.19
-9 059.37
-10.81 K
-10.49 K
-13.56 K
0.94
Net margin %
-187.04
10.94 K
2 701.82
-7 854.2
-9 868.79
-375.56
46.38
Liquidity ratios
Quick ratio
4.08
—
—
—
—
—
1.94
Current ratio
4.12
4.79
3.25
4.09
1.69
2.76
1.95
Inventory turnover
0.72
—
—
—
—
—
0.95
Asset turnover
0.46
0.01
0
0
0
0
0.1
Solvency ratios
Debt to assets ratio
1.31
0.75
0.53
0.56
0.68
0.21
0.15
Debt to equity ratio
-1.97
13.21
3.68
-8.53
-1.03
-0.57
-0.82
Long term debt to total assets ratio
1.31
0.75
0.53
0.56
0.6
0.27
0.15
Long term debt to total equity ratio
-1.96
13.18
3.68
-8.53
-0.9
-0.73
-0.82
Per share metrics
Operating cash flow per share
—
-1.76
-1.38
1.19
-2.56
-1.83
-1.02
EBIT per share
—
-2.76
-2.58
-2.6
-2.88
-1.92
-1.05
EBITDA per share
—
-2.71
-2.53
-2.58
-2.87
-1.9
-1.03
Total debt per share
—
5.04
5.03
3.4
3.24
1.09
0.47
Cash per share
—
2.52
3.11
2.74
1.55
2.71
1.47
Net current asset value per share
—
3.98
7.06
3.47
2.31
3.4
2.07
Tangible book value per share
—
0.38
1.37
-0.4
-3.14
-1.91
-0.57
Working capital per share
—
3.15
4.89
2.62
0.94
2.17
1.01
Book value per share
—
0.38
1.37
-0.4
-3.14
-1.91
-0.57
News
This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Dow Jones Futures: Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst
Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?
Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Omeros: YARTEMLEA Is Off To A Blistering Start (NASDAQ:OMER)
This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why
Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript
Omeros (OMER) Q2 Earnings and Revenues Beat Estimates
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now